The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption

Planta Medica

Volumn 69, Issue 7, 2003, Pages 632-636

  Pan, Guo Yu ^a   Huang, Zhi Jiang ^a   Wang, Guang Ji ^a   Fawcett, J Paul ^b   Liu, Xiao Dong ^a   Zhao, Xiao Chen ^a   Sun, Jian Guo ^a   Xie, Yuan Yuan ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Alpha glucosidase inhibitor; Berberine; Caco 2 cells; Diabetes

Indexed keywords

ALPHA GLUCOSIDASE; ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BERBERINE; DEOXYGLUCOSE; DISACCHARIDASE; SUCRASE;

ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; DRUG STRUCTURE; ENZYME INHIBITION; GLUCONEOGENESIS; GLUCOSE ABSORPTION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; MONOLAYER CULTURE;

ALPHA-GLUCOSIDASES; BERBERINE; CACO-2 CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUCONEOGENESIS; GLUCOSE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; SUCRASE;

EID: 0041379639     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-41121     Document Type: Article

References (21)

1. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci USA 2000; 97: 1433-7
2. Taylor CT, Winter DC, Skelly MM et al. Berberine inhibits ion transport in human colonic epithelia. Eur J Pharmacol 1999; 368: 111-8
3. Hua Z, Wang XL. Inhibitory effect of berberine on potassium channels in guinea pig ventricular myocytes. Acta Pharmaceutica Sinica 1994; 29: 576-80 (in Chinese)
4. Hua WG, Song JM, Liao H et al. Effect of Huang Lian Su on nerve conduction velocity and hormone level to diabetic neuropathy in rats. Labeled Immunoassays & Clin Med 2001; 8: 212-4 (in Chinese)
5. Sheng MP, Sun Q, Wang H. Studies on the intravenous pharmacokinetics and oral absorption of berberine HCl in beagle dogs. Sin Pharmacol Bull 1993; 9: 64-7
6. Pan GY, Wang GJ, Liu XD et al. The involvement of P-glycoprotein in berberine absorption. Pharmacology & Toxicology 2002; 91: 193-7
7. Ruppin H, Hagel J, Feuerbach W, Schutt H, Pichl J, Hillebrand I et al. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study. Gastroenterology 1988; 95: 93-9
8. 14C] acarbose to rats, dogs and man. Arzneimittelforschung 1989; 39: 1254-60
9. Dahlqvist A. Method for assay of intestinal disaccharidases. Analytical Biochemistry 1964; 7: 18-25
10. Susumu H, Eiko A, Shigeo S, Masahiro O, Kazuaki K, Jun N. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrazolone derivatives. Analytical Biochemistry 1989; 180: 351-7
11. Fu D, O'Neill RA. Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography. Analytical Biochemistry 1995; 227: 337-84
12. +-dependent sugar transport in Caco-2 cells and human fetal colon. J Membr Biol 1987; 99: 113-25
13. Balfour JA, McTavish D. Acarbose, an update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 1994; 48: 929
14. Brogard JM, Willemin B, Blickle JF, Lamalle AM, Stahl A. Alpha-glucosidase inhibitors: a new therapeutic approach in diabetes and functional hypoglycemia. Rev Med Interne 1989; 10: 365-74
15. Campbell LK, Baker DE, Campbell RK. Miglitol: assessment of its role in the treatment of patients with diabetes mellitus. Ann Pharmacother 2000; 34: 1291-301
16. Clissold SP, Edwards C. Acarbose: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1988; 35: 214-43
17. Sels JP, Huijberts MS, Wolffenbuttel BH. Miglitol, a new alpha-glucosidase inhibitor. Expert Opin Pharmacother 1999; 1: 149-56
18. Lee SM, Bustamante S, Flores C, Bezerra J, Goda T, Koldovsky O. Chronic effects of an α-glucosidase inhibitor (Bay o 1248) on intestinal disaccharidase activity in normal and diabetic mice. J Pharmacol and Exp Ther 1987; 240: 132-7
19. Radziuk J, Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 2001; 17: 250-72
20. Meyerson LR, McMurtrey KD, Davis VE. Isoquinoline alkaloids. Inhibitory actions on cation-dependent ATP-phosphohydrolases. Neurochem Res 1978; 3: 239-57
21. Toshihiro M, Mami K, Eriko I, Yutaka S, Keiichiro T. Antidiabetic mechanism of Bakumondoinshi. Biol Pharm Bull 1999; 22: 388-90